Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-partner versus female-only antibiotic treatment for bacterial vaginosis
ACTRN12618000219280Phase 2Completed
- Sponsor
- Monash University
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metronidazole and clindamycin in bacterial vaginosis (BV) (2 arms), sponsored by Monash University. Primary endpoint: Acceptability and tolerability of male partner treatment. Started Mar 2018; status: completed.
02
Drugs
metronidazoleclindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ACTRN12618000219280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000219280.